Distinct in vivo target occupancy by bivalent- and induced-fit-like binding drugs.

Closer attention should be paid to more complex binding models in PK-PD simulations. This may help pharmacologists and medicinal chemists to improve the translation of in vitro kinetic measurements from preclinical screening programmes into clinical efficiency.